PD-L1 Immunohistochemistry Comparability and Their Correlation with Clinical Characteristics in NSCLC

BACKGROUND: PD-L1 expression is an important predictive factor of response to therapy with immune checkpoint inhibitors (ICIs). This study was designed to retrospectively analyze the concordance of PD-L1 measurements using three different assays (Dako22C3, Dako28-8, and SP142) in NSCLC patients and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Anal Cell Pathol (Amst)
Main Authors: Wu, Chiao-En, Chang, Ching-Fu, Kou-Sheng, Liao, Chiang, Ju, Lee, Shih-Wei, Chiu, Yu-Chi
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7655253/
https://ncbi.nlm.nih.gov/pubmed/33204603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3286139
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados